Ranger Investment Management L.P. Acquires Shares of 319,253 HealthEquity, Inc. $HQY

Ranger Investment Management L.P. bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) in the second quarter, Holdings Channel reports. The firm bought 319,253 shares of the company’s stock, valued at approximately $28,835,000. HealthEquity comprises 1.8% of Ranger Investment Management L.P.’s holdings, making the stock its 16th biggest position.

Several other institutional investors and hedge funds also recently made changes to their positions in HQY. Acumen Wealth Advisors LLC acquired a new position in shares of HealthEquity in the 4th quarter valued at $27,000. Caitong International Asset Management Co. Ltd grew its stake in shares of HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after purchasing an additional 293 shares during the period. Aster Capital Management DIFC Ltd acquired a new stake in shares of HealthEquity during the fourth quarter worth $28,000. Leonteq Securities AG increased its holdings in HealthEquity by 159.9% in the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after purchasing an additional 235 shares during the last quarter. Finally, Axiom Investment Management LLC bought a new stake in HealthEquity in the first quarter valued at about $33,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of HQY stock opened at $105.41 on Monday. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $107.62. The firm has a fifty day moving average of $96.64 and a 200-day moving average of $87.20. The firm has a market capitalization of $8.81 billion, a price-to-earnings ratio of 39.48, a price-to-earnings-growth ratio of 1.77 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.11 by $0.13. The business had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities research analysts forecast that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

Insiders Place Their Bets

In other HealthEquity news, EVP Michael Henry Fiore sold 2,354 shares of the stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $95.00, for a total value of $223,630.00. Following the completion of the sale, the executive vice president directly owned 52,244 shares in the company, valued at $4,963,180. This represents a 4.31% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the firm’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the sale, the director directly owned 19,733 shares in the company, valued at approximately $1,775,970. This represents a 11.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 17,905 shares of company stock worth $1,651,280 over the last ninety days. 1.60% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

HQY has been the topic of several analyst reports. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. KeyCorp restated an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Barrington Research reaffirmed an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a research note on Friday, May 22nd. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, BTIG Research increased their price target on shares of HealthEquity from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Friday, July 24th. Eleven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and a consensus target price of $110.93.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.